Experience in switching monoclonal antibodies in a patient with severe refractory atopic dermatitis: from Dupilumab to Abrocitinib. Case report . (2025). Revista Alergia México, 72(4), 382-385. https://doi.org/10.29262/ram.v72i4.1547